Elaine R Mardis, PhD

Elaine Mardis


College of Medicine



Academic Title


Research Program

Translational Therapeutics

Elaine Mardis, PhD, is a member of the Translational Therapeutics Program at the OSUCCC – James, where she focuses her research on cancer genomics from a discovery and a translational point of view.

In particular, she seeks to identify the best therapeutic approaches to fighting an individual’s cancer by determining common driver mutations/genes and pathways that can cause cancer to develop and progress.

She is the co-holder of five U.S. patents, including her most recent one for patient-specific, mutation-directed immunotherapy for cancer.

One of her recent studies involved a clinical trial of a personalized DNA vaccine plus immune modulation of the tumor microenvironment in patients with resected pancreatic cancer.

Dr. Mardis has co-authored more than 250 articles in well-respected publications, including Cell, Journal of Clinical Oncology, Blood and Cancer Epidemiology, Biomarkers & Prevention. She has also shared her research in many presentations to prestigious organizations, such as the American Association for Cancer Research, Association of Biomolecular Resource Facilities, American Society of Human Genetics and American Society of Clinical Oncology.


  • Doctorate, University of Oklahoma

    Norman, OK (USA)

  • Doctorate, University of Oklahoma

    Norman, OK (USA)

Office Location

The Institute for Genomic Medicine

700 Children’s Drive, Columbus, OH 43205



Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication